Dashboard
Manage Tickers

ZYMEZymeworks Inc.

Nasdaq zymeworks.com


$ 11.80 $ 0.17 (1.47 %)    

Thursday, 05-Sep-2024 15:11:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 11.76
$ 11.78 x 100
$ 11.81 x 100
-- - --
$ 6.02 - $ 13.14
736,117
na
740.84M
$ 0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 03-06-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-07-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stifel-maintains-buy-on-zymeworks-raises-price-target-to-21
Stifel Maintains Buy on Zymeworks, Raises ...
08/02/2024 17:58:37

Stifel analyst Stephen Willey maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $20 to $21.

zymeworks-files-for-common-stock-offering-of-up-to-150m
Zymeworks Files For Common Stock Offering ...
08/02/2024 11:06:16

-424B5

zymeworks-announces-share-repurchase-program-of-up-to-60m-of-common-stock
Zymeworks Announces Share Repurchase Progr...
08/01/2024 21:18:04

Zymeworks Inc. (NASDAQ:ZYME) (the "Company"), a clinical-stage biotechnology company developing a diverse pipeline of n...

zymeworks-q2-2024-gaap-eps-049-misses-007-estimate-sales-19243m-miss-48860m-estimate
Zymeworks Q2 2024 GAAP EPS $(0.49) Misses ...
08/01/2024 20:40:54

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $0.07 by 80...

zymeworks-appoints-leone-patterson-as-executive-vice-president-and-chief-business-and-financial-officer-effective-september-1-2024
Zymeworks Appoints Leone Patterson As Exec...
07/25/2024 20:43:03

zymeworks-says-fda-has-cleared-investigational-new-drug-application-for-zw191
Zymeworks Says FDA Has Cleared Investigati...
07/22/2024 10:02:30

ZW191 is the Company's novel folate receptor-⍺ (FR⍺) targeted topoisomerase I inhibitor (TOPO1i) antibody-drug conjugate (A...

Core News & Articles
Market-Moving News for June 17th
06/17/2024 12:40:12

BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106 ZYME: 13% | Zymeworks shares are trading higher after t...

zymeworks-shares-are-trading-higher-after-the-fda-cleared-the-companys-investigational-new-drug-application-for-zw171-for-mesothelin-expressing-cancers-with-the-company-expecting-to-initiate-clinical-development-during-2024
Zymeworks shares are trading higher after ...
06/17/2024 11:45:40

fda-clears-zymeworks-investigational-new-drug-application-for-zw171-for-mesothelin-expressing-cancers-the-company-expects-to-initiate-clinical-development-of-zw171-during-2024
FDA Clears Zymeworks' Investigational New ...
06/17/2024 10:03:10

zymeworks-achieves-key-milestone-with-bla-acceptance-for-zanidatamab-in-china-zymeworks-to-receive-up-to-164m-in-milestone-payments
Zymeworks Achieves Key Milestone with BLA ...
06/10/2024 10:02:52

 Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional b...

navigating-6-analyst-ratings-for-zymeworks
Navigating 6 Analyst Ratings For Zymeworks
06/06/2024 12:00:39

hc-wainwright--co-reiterates-neutral-on-zymeworks-maintains-10-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/06/2024 10:17:58

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

zymeworks-stock-a-deep-dive-into-analyst-perspectives-5-ratings
Zymeworks Stock: A Deep Dive Into Analyst ...
05/07/2024 13:00:42

hc-wainwright--co-reiterates-neutral-on-zymeworks-maintains-10-price-target
HC Wainwright & Co. Reiterates Neutral on ...
05/07/2024 10:21:13

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

citigroup-maintains-buy-on-zymeworks-lowers-price-target-to-16
Citigroup Maintains Buy on Zymeworks, Lowe...
05/03/2024 21:57:07

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and lowers the price target from $17 to $16.

wells-fargo-maintains-overweight-on-zymeworks-lowers-price-target-to-12
Wells Fargo Maintains Overweight on Zymewo...
05/03/2024 18:04:42

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and lowers the price target from $14 t...

zymeworks-q1-2024-gaap-eps-042-misses-029-estimate-sales-10030m-miss-17431m-estimate
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses ...
05/02/2024 20:27:21

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by ...

zymeworks-presents-new-data-from-multiple-preclinical-development-programs-at-2024-american-association-for-cancer-research-annual-meeting
Zymeworks Presents New Data from Multiple ...
04/08/2024 10:05:55

Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional bi...

wells-fargo-maintains-overweight-on-zymeworks-raises-price-target-to-14
Wells Fargo Maintains Overweight on Zymewo...
03/12/2024 11:17:18

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $12 t...

hc-wainwright--co-maintains-neutral-on-zymeworks-raises-price-target-to-10
HC Wainwright & Co. Maintains Neutral on Z...
03/11/2024 10:41:44

HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Neutral and raises the price target fr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION